Recipientes esterilizables en autoclave con tapa cilíndrica, 19 l, 1 unidad

tert-Butyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate, 95.0%, 25g

Potassium (3-ethoxy-3-oxopropyl)trifluoroborate, 95.0%, 5g

5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

9-(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole, 98+%, 500mg

(S)-4-Boc-2-Hydroxymethyl-morpholine, 97.0%, 100g

3-Bromo-2,5-diaminopyridine, 95.0%, 100g

6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 5g

3'-Dimethylaminoacetophenone, 98%, 5g

N-(2-amino-4-methylphenyl)propanamide, 95.0%, 10g

Methyl 3-Bromo-4-fluorobenzoate>98.0%(GC)1g

2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 95+%, 1g

2,3-Diphenylindole, 95.0%, 10g